Book articles, Book editions, Published abstracts
Book articles first author
K. H. Link, J.Ritter.
Inselzelltumoren und Zysten der Bauchspeicheldrüse – Diagnose und Chirurgische Therapie von
Bauchspeicheldrüsentumoren bei VHL-Patienten.
G.Alsmeier (VHL), P.H.Neumann (Ed.): Von Hippel-Lindau (VHL). Eine patientenorientierte
Krankheitsbeschreibung.
Books on Dermand, Norderstedt, 2010, 41-45
K. H. Link, M. Hauser, M. Mann, P. M. Schlag.
Kolonkarzinom
Chirurgische Onkologie Strategien und Standards für die Praxis
Michael Gnant, Peter M. Schlag (Hrsg.), Kapitel 23, 315-329
Springer Wien/New York, 2008
K. H. Link, J. Preiß.
Prinzipien der lokoregionären Chemotherapie.
in H.-J. Schmoll, K. Höffken, K. Possinger (Hrsg.):
Kompendium Internistische Onkologie, 4. Auflage
Standards in Diagnostik und Therapie
Springer, 873-881, 2006
K. H. Link, V. Apell, K. Tischbirek, M. Holtappels, K. Zayed, T.A. Sagban, M. Mörschel, T.F.
Weigel, K.M. Josten, R. Thimm, L. Staib.
Multimodality Treatment of Hepatic Metastases.
In Focal Liver Lesions, Editors R. Lencioni, D. Cioni, C. Bartolozzi
Springer, 363-387, 2005
K. H. Link.
Chirurgisch-onkologische Therapie von Mammakarzinomlebermetastasen
Management des Mammakarzinoms, R. Kreienberg, T.Volm, V. Möbus, D. Alt, Springer, 2. Auflage, 2002, 271-277K. H. Link.Chirurgisch-onkologische Therapie von Mammakarzinom-Lebermetastasen.
In: R. Kreienberg (Hrsg): Management des Mammakarzinoms. Ein Leitfaden für die Praxis. Springer,
Heidelberg (1998) 274-281
K. H. Link, L. Staib, H.G. Beger.
Adjuvante Therapie bei soliden Tumoren des unteren
Gastrointestinaltraktes. In: H.G. Beger, A. Schwarz, U. Brückner, W. Hartel (Hrsg): Forschung in der Chirurgie. Springer, Heidelberg (1997) 150-169
K. H. Link, F. Gansauge, J. Pillasch, M. Büchler, H.G. Beger.
Regional Treatment of Advanced Pancreatic Carcinoma via Celiac Axis Infusion.
In: H.G. Beger, M. Büchler, M.H. Schoenberg (Eds)
Cancer of Pancreas, Universitätsverlag Ulm (1996) 459-465
K. H. Link, E.D. Kreuser, F. Safi, A. Schalhorn, E. Schmoll, J. Pillasch, H.G. Beger.
5-FU+Folinic Acid (FA, Rescuvolin) i.a., 5-FU+FA i.v., 5-FUDR i.a., or 5-FUDR i.a.+ i.v. for treatment of nonresectable colorectal liver metaastases?
In: P. Banzet, J.F. Holland, D. Khayat, M. Weil (Eds): Cancer Treatment. An Update.
Springer, Paris (1994) 639-648.
K. H. Link, F. Safi, H.G. Beger.
Ergebnisse der Tumornachsorge bei 1054 Patienten mit kolorektalen
Karzinomen. Was bringt der Aufwand? in: Berichte über die Jahrestagung der ATO 11
(Krebsverband Baden-Württemberg) (1992) 17-25
K. H. Link.
Basic concepts for the application of Mitomycin C in regional cancer treatment.
In: T. Taguchi, K.R. Aigner (Eds.): Mitomycin C in Cancer Chemotherapy Today,
Excerpta Medica, Tokyo (1991) 62-71
K. H. Link, R. Kunz, J. Ullrich, H.G. Beger.
Drug sensitivity testing for regional chemotherapy.
In: P. Banzet, J.F. Holland, D. Khayat, M. Weil (Eds): Neo-Adjuvant Chemotherapy.
Springer, Berlin (1991) 248-251
K. H. Link.
Chemosensitvity-directed regional chemotherapy of liver metastases.
In: H.G. Beger et.al. (Eds.): Cancer Therapy. Springer, Berlin (1989) 249-258
K. H. Link.
Drug testing in regional chemotherapy of liver metastases.
In: J. Kreidler, K. H. Link, K.R. Aigner (Eds): Advances in Regional Chemotherapy.
Karger, Basel (1988) 79-91
K. H. Link, W. Kühn, K.R. Aigner.
In vitro bioassay for testing perfusate toxicity in isolation perfusion of extremity melanoma.
In: S. Salmon (Ed): Adjuvant therapy of cancer.
Grune & Stratton, Orlando (1987) 679-688
K. H .Link.
Chemosensitivitätstestung von Mitoxantron zur Eignung in der hochdosierten
regionalen Kurzzeittherapie.
In: S. Seeber., K.R. Aigner, E. Enghofer (Eds): Die Lokoregionale Tumortherapie.
De Gruyter, Berlin (1987) 13-19
K. H. Link, K.R. Aigner, K. H. Schultheis, W. Kühn, H. Walther, K. Schwemmle.
In-Vitro Sensitivitätstestung von Cytostatika bei regionaler Chemotherapie von (Melanom-)
Lebermetastasen.
In: H. Voigt und U.R. Kleeberg: Malignes Melanom
Springer, Berlin (1986) 307-314
K. H. Link, K.R. Aigner, K. H. Schultheis, W. Kühn, H. Walther, K. Schwemmle.
High dose regional chemotherapy in melanoma liver metastases. Prediction of response in vitro.
Proceedings of the 1st. International Conference On Skin Melanoma, Venice (1985) 153-161
K. H. Link, J. Dobroschke, K. H. Sommerlad, H. Mueller.
Abdominal Surgery in Patients on Chronic Hemodialysis.
In FW Eigler and HD Jakubowski (eds.): Surgery in Chronic Renal Failure.
Thieme, Stuttgart – New York, (1983) 164-167
K. H. Link, K.R. Aigner, P. Hild, K. Henneking.
The isolated extremity perfusion in melanomas and soft tissue sarcomas with Cis-Platinum, DTIC, and
Vindesine.
In: K. H. Spitzy and K. Karrer (Eds.):
Proceedings of the 13th International Congress of Chemotherapy, Vienna (1983) 258/14-18
Book articles coauthor
– Book articles coauthor
Th. Weber und K.H. Link.
Was gibt es Neues bei Mindestmengenvereinbarungen?
In: Meßmer, Jähne, Neuhaus Eds: Was gibt es Neues in der Chirurgie, Jahresband 2011,
ecomed, 511-520
A. Schalhorn, K.H. Link, W. Voigt.
Regionale Chemotherapie von Lebermetastasen
In: H.-J. Schmoll, K. Höffken, K. Possinger (Hrsg.). Kompendium Internistische Onkologie, 4. Auflage
Standards in Diagnostik und Therapie. Springer, 873-881, 2006
M. Schulte, K.H. Link, L. Sunder-Plassmann.
Operative Therapie bei (Mammakarzinom) Metastasen
In (R. Kreienberg, T. Volm, V. Möbus, D. Alt, (Eds)):
Management des Mammakarzinoms, 2. Auflage, Springer, Heidelberg 2002, 258-277
F. Gansauge, K.H. Link, A. Formentini, M. Schatz, R. Röttinger, J. Görich, H.G. Beger.
Adjuvant intra-arterial chemotherapiy with and without radiation therapy in pancreatic cancer
Pancreatic Cancer,
in: D. B. Evans, P. W. T. Pisters, J. L. Abruzzese (Editors):
Pancreatic Cancer, Springer, New York, 2001; 275-279
Paula Ghaneh, David Smith, Jennifer Almond, Deborah Moffitt, Janet Dunn, John Slavin, Robert
Sutton, Claudio Passi, Paolo Pederzoli, Hans G. Beger, K. H. Link, Helmut Freiss, Markus Büchler,
John P. Neoptolemos.
European adjuvant trials in pancreatic cancer.
In: D. B. Evans, P. W. T. Pisters, J. L. Abruzzese (Editors):
Pancreatic Cancer, Springer, New York, 2001, 255-267
M. Schulte, K.H. Link, L. Sunder-Plassmann.
Operative Therapie des Mammakarzinoms bei Metastasen.
In: R. Kreienberg, V. Möbus, D. Alt (Hrsg): Management des Mammakarzinoms.
Springer, Heidelberg (1998) 261-287
R.W.Dahlbender, C. Grünwald, G. Allert, D. Pokorny, K.H. Link, H. Kächele.
Zum Beziehungs- und Interaktionsangebot des Liaisonpsychotherapeuten in einem chirurgisch-
onkologischen Team.
In: R. Battegay, A.M. Däumling et al. (Eds): Gruppenpsychotherapie und Gruppendynamik,
Vandenhoeck & Ruprecht, Göttingen, Zürich 32 (1996) 235-255
H. G. Beger, K.H. Link, B. Poch.
Therapie der chronischen Pankreatitis.
In: Boeckl, Waclawiczek (Hrsg.): Standards in der Chirurgie.
W. Zuckschwerdt-Verlag München (1995)
H. G. Beger, K.H. Link, B. Poch, F. Gansauge.
Pancreatic cancer – recent progress in diagnosis and treatment.
In: Neoptolemos J.P., Lemoine N.R. (Eds.): Pancreatic Cancer. Molecular and Clinical Advances.
Blackwell Science Oxford (1995) 227-235
R. Schönmayr, J.C. Tonn, K.H. Link, H.P. Krämer.
Chemosensitivity of malignant human brain tumors In vitro.
In: J. Kreidler, K.H. Link, K.R. Aigner (Eds): Advances in Regional Cancer Therapy.
Karger, Basel (1988) 157-166
K.R. Aigner, K.H. Link, H. Walther.
Chirurgische Therapie des malignen Melanoms.
In: H. Voigt und U.R. Kleeberg (Eds.)
Malignes Melanom. Springer, Berlin (1986) 119-126
K.R. Aigner, H. Walther, K.H. Link.
Perfusionstherapie (beim malignen Melanom).
In: H. Voigt und U.R. Kleeberg (Eds.): Malignes Melanom. Springer, Berlin (1986) 299-305
M. Schartl, R.U. Peter, K.H. Link, G. Klaus, Ch. Gisa.
Behaviour of fish melanomas after transplantation onto nude mice.
Proc. 1.Int. Conf. on Skin Melanoma, Venedig (1985) 221-222
H. Walther, K.R. Aigner, K.H. Link, HJ Helling, K. Schwemmle.
Prevention of edema in isolated hyperthermic perfusion of the extremities.
Proc. 1. Int.Conf. on Skin Melanoma, Venedig (1985) 84-85
K.R. Aigner, H. Walther, K.H. Link, K.H. Muhrer, K. Schwemmle.
Isolation perfusion of the liver as part of a multimodal therapeutic concept for liver metastasis.
In: H.O. Klein: Advances in the Chemotherapy of Gastrointestinal Cancer.
Perimed, Erlangen (1984) 117-125
K.H. Muhrer, C. Johnsen, K.H. Link, K.R. Aigner.
Carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) for therapy control after intra-
arterial chemotherapy of liver metastases. In: H.O. Klein: Advances in the Chemotherapy of
Gastrointestinal Cancer,
Perimed, Erlangen (1984) 127-131
P. Schoch, K.R. Aigner, F. Schumacher, Z. Akengin, K.H. Link, S. Bayindir.
Volumetry of liver metastases in cat-scan before and after regional liver perfusion and infusion.
In: K.H. Spitzy, H.Karrer (Eds.): Proceedings of the 13th International Congress of Chemotherapy,
Wien (1983) 282/1-3
Books Editor/Coeditor etc.
K. H. Link, P. Heeckt, D. Klein, M. Schatz (Eds)
Ernährung und Krebs. Fabri-Verlag, Ulm (2000).
K. H. Link, D. Klein, P. Heeckt (Eds)
Ernährung und Krebs. Oncological Seminar, Ulm Cancer center. CD-Rom ,1999.
H. G. Beger, K.H. Link (Eds)
Gastroenterological Carcinogenesis. Monduzzi, 1999..
K. H. Link
Proceedings of the 8th International Conference of Regional Cancer Treatment.
Regional Therapy of Cancer – The Future. Regional Cancer Treatment, Supplement I, (1997) 1-83.
K. R. Aigner, Y. Patt, K. H. Link, J. Kreidler
Regional Cancer Treatment. Karger, Basel (1988).
J. Kreidler, K. H. Link, K. R. Aigner.
Advances in Regional Cancer Therapy.
Proceedings of the III. International Conference on Advances in Regional Cancer Therapy (ICRCT 87), Karger, Basel (1988).
Abstracts (Published abstracts for congress presentations)
First author
K. H. Link, W. Weidner, J. Kracht, C.F. Rothauge.
Immunhistologische CEA-Darstellung in Blasentumoren – Erste Ergebnisse. Tagungsbericht der 26. Tagung der Nordrhein-Westfälischen Gesellschaft für Urologie (1980) 62
K. H. Link, K.R. Aigner, H. Müller, K. Schwemmle.
DTIC, Vindesine, and Cis-DDP in isolated extremity perfusion.
Cancer Research and Clinical Oncology 107 (1984) 61
K. H. Link, K.R. Aigner, H. Müller, K. Schwemmle.
DTIC, Vindesine, and Cis-DDP in isolated extremity perfusion.
Verh. Dtsch. Krebs. Ges. 5, G. Fischer, Stuttgart (1984) 138
K. H. Link, K.R. Aigner, W. Kuehn, K. Schwemmle.
Wachstumshemmung colorektaler Lebermetastasen in vitro nach interoperativer hochdosierter regionaler Chemotherapie.
Aktuelle Onkologie 28, Zuckschwerdt, München (1985) 248,
K. H. Link, K.R. Aigner, W. Kühn, K. Schwemmle, K. H. Schultheis.
Perioperative response determination in vitro in regional chemotherapy of colorectal liver metastases.
Proceedings of ECCO 3, Stockholm (1985) 208,
K. H. Link, K.R. Aigner.
Immediate response determination in vitro following drug exposition in vitro by regional chemotherapy.
Journal of Cancer Research and Clinical Oncology, Suppl. to Vol. 111, (1986) 98
K. H. Link, K.R. Aigner, K. Schwemmle.
Drug Testing in Regional Chemotherapy.
J Cancer Res Clin Oncol, Suppl. to 111, (1986) 97
K. H. Link, K.R. Aigner, C. Peschau.
Concentration-time-dependant toxicity of 5-FU, 5-FUR, and 5-FUDR in colorectal carcinoma cell line HT 29.
J Cancer Res Clin Oncol, Suppl. to 111, (1986) 93
K.H .Link, D. Kessler, K.R. Aigner.
Dose response of Mitoxantrone in cell lines and human solid tumor biopsies with first results in regional chemotherapy.
J Cancer Res Clin Oncol, Suppl. to 111, (1986) 93
K. H. Link, K.R. Aigner, D.H. Kern, K.P. Ramming.
Chemosensitivity testing in high-dose regional chemotherapy
Proceedings of the 77th AACR Meeting, Los Angeles (1986) 416
K. H. Link, Ch. Gisa, K. H. Muhrer, H.P. Fischer, M. Altmannsberger, A. Köhler.
Immunoreactivity of colorectal carcinoma celline NMG 64/84 in the electropheresis mobility test.
J Cancer Res Clin Oncol 113 (1987) 43
K. H. Link, D Kessler, K.R. Aigner, K. Schultheis.
Chemosensitivity profiles of human solid tumors to various drugs.
J Cancer Res Clin Oncol 113 (1987)54
K. H. Link, K. Peschau, N. Rötering.
Influence of concentration and exposure time on toxicity in the dual action of 5-FU in HT29 colorectal carcinoma cells.
J Cancer Res Clin Oncol 113 (1987) 54
K. H. Link, H.G. Beger.
Individual drug selection for regional chemotherapy by in vitro testing.
J Cancer Res Clin Oncol 114, (1988) 179
K. H. Link, C.H. Gisa, K. H. Muhrer, H.G. Beger.
T-cell dependent screening system to detect colon carcinoma.
J Cancer Res Clin Oncol 114, (1988) 22
K. H. Link, R. Kunz, L. Staib, J. Sixt.
Drug selection by sensitivity testing at the high concentrations in regional chemotherapy.
European Surgical Research 22, S1/90, (1990) 60
K. H. Link, J.M. Friedrich, R. Kunz.
Transcutaneously accessible endoprosthesis for transduodenal bile drainage in inoperable occlusive jaundice.
European Surgical Research 22, S1/90, (1990) 22
K. H. Link, R. Kunz, L. Staib, H.G. Beger.
Drug exposure concentration and -time as determinants of toxicity.
Cancer Research and Clinical Oncology, 116 (1990) 452
K. H. Link, R. Kunz, G. Hepp.
Intraperitoneal regional chemotherapy (IPRC) with mitoxantrone (NOV).
Regional Cancer Treatment 4 (1991) 27
K. H.Link, R. Kunz, J. Ullrich, H.G. Beger.
Chemosensitivity tests predict response to regional chemotherapy.
European Journal of Cancer, Suppl 2 (1991) 205
K. H. Link, G. Hepp, W. Böhm, H.G. Beger.
Novantrone (NOV). Intraperitoneal application – basic concepts and clinical results.
J Cancer Res Clin Oncol, 118 Suppl (1992) R169
K. H. Link, J. Ullrich, A. Schalhorn, H.G. Beger.
Hepatic artery infusion (HAI) with 5-Fluorouracil and folinic acid (FA) in colorectal liver metastases (CRLM) via ports.
J Cancer Res Clin Oncol, 118 Suppl (1992) R7
K. H. Link, D. Kindler, M. Hummel, M. Büchler.
Dose response treatment studies with two pancreatic carcinoma cell lines in vitro.
Digestion 52, (1992) 102
K. H. Link, J. Ullrich, R. Kunz, H.G. Beger.
Die Wertigkeit der In-vitro-Sensitivitätstestung (IVS) von Zytostatika.
Acta Chirurgica Austriaca (ACA) 98 (1992) 59-60
K. H. Link.
Pharmacology in regional chemotherapy. A review. Regional Cancer Treatment
Suppl.1, (1993) 35
K. H. Link.
Impact of chemosensitivity testing on regional chemotherapy.
Regional Cancer Treatment Suppl.1, (1993) 36
K. H. Link, E.D. Kreuser, F. Safi, J. Ullrich, J. Pillasch.
Optimal fluoropyrimidine therapy of colorectal liver metastases.
Regional Cancer Treatment Suppl.1, (1993) 36
K. H. Link.
Possibilities and developments in regional chemotherapy of malignant liver tumors. A review.
Regional Cancer Treatment Suppl.1, (1993) 36
K. H. Link, J. Pillasch, F. Safi, F. Gansauge, H.G. Beger.
Advantages of Regional Chemotherapy in malignant Liver Tumors.
J Cancer Res Clin Oncol 120 (1994) 74
K. H. Link, H.G. Beger.
Rationales for Adjuvant Therapy in Carcinomas of the Colon and Rectum.
J Cancer Res Clin Oncol 120 (1994) 19
K. H. Link.
Possibilities of Regional Chemotherapy in Extrahepatic Tumor Sites.
J Cancer Res Clin Oncol 120 (1994) 148
K. H. Link, K.R. Aigner, J. Pillasch, J. Ullrich, F. Gansauge and D.H Kern.
A Prospective Decision-Aiding Trial Used to Select Individualized Treatment Regimens for Patients Undergoing Regional Chemotherapy.
Proceedings of the AACR, 35 (1994) 205
K. H. Link, L. Staib, J. Pillasch, F. Gansauge, U. Butzer, H.G. Beger.
Concentration Response Behaviour of Human Solid Tumor Cells to Chemotherapeutic Drugs In Vitro. Proceedings of the AACR, 35 (1994) 433
K. H. Link, J. Pillasch, M. Weindel, H.G. Beger.
Hepatic arterial infusion therapy (HAI) for treatment of isolated nonresectable colorectal liver metastases (CRLM). Mitoxantrone (NOV), 5-FU+Folinic Acid (FA), Mitomycin C (MMC) as standard therapy?.
Proceedings of the Sixth International Congress on Anti-Cancer Treatment, Paris (1996) 135
K. H. Link.
Adjuvant therapy in pancreatic cancer.
Proceedings of the Sixth International Congress on Anti-Cancer Treatment, Paris (1996) 49
K. H. Link, J. Pillasch, M. Weindel, U. Widmaier, F. Gansauge, H.G. Beger.
Regional chemotherapy of nonresectable isolated colorectal liver metastases (CRLM): Mitoxantrone (NOV), 5-FU+folinic acid (FA), and Mitomycin C (MMC) versus 5-FU+FA.
Proceedings of the American Association for Cancer Research 37 (1996) 170
K. H. Link, J. Pillasch, M. Weindel, G. Leder, H. G. Beger.
Mitoxantrone, 5-FU + Folinic Acid, Mitomycin C for regional Chemotherapy of malignant Liver Tumors.
Proceedings of the 18th Society Meeting, Japanese Society for Research of Loco-Regional Cancer Therapy, Hiroshima (1996) 28
K. H. Link, J. Pillasch, H. G. Beger.
Regionale Chemotherapie von Lebertumoren nach individueller Chemosensitivitätstestung.
Abstractband, 22. Deutscher Krebskongreß Berlin, Omnimed-Verlag, Hamburg (1996) 119
K. H. Link, J. Pillasch, M. Weindel, H.G. Beger.
Intraarterielle Infusion (HAI) zur Behandlung isolierter nichtresektabler colorektaler Lebermetastasen (CRLM): Mitoxantrone (NOV), 5-FU+Folinsäure (FS), Mitomycin C (MMC) vs. 5-FU+FS.
Langenbecks Arch. Chir., Suppl. I, Chirurgisches Forum (1996) 620
K. H. Link.
Standards/Studies. Regional or systemic treatment in liver metastatic tumors, FOGT 3- Study.
Regional Cancer Treatment, Suppl. 1, (1997) 72
K. H. Link .
Standards and studies for advanced pancreatic cancer.
Regional Cancer Treatment, Suppl. 1, (1997) 73
K. H. Link, J. Pillasch, M. Weindel, G. Leder, H.G. Beger.
Mitoxantrone, 5-FU + Folinic Acid, Mitomycin C for Regional Chemotherapy of Malignant Liver Tumors.
Jap. J. Cancer and Chemotherapy 23 (1997) 1380
K. H. Link, J. Pillasch, M. Weindel, A. Formentini, F. Safi, J. Limmer, H.G. Beger.
Development of regional chemotherapy in nonresectable colorectal liver metastases. Rationale for a randomized trial.
Proceedings – Seventh International Congress on Anti-Cancer Treatment, Paris (1997) 95
K. H. Link, G. Leder, G. Hepp, H. Urbanczyk, H. Schmid.
Retrospective analysis of intraperitoneal instillative chemotherapy with Mitoxantrone in 143 patients with malignant ascites of breast and gynecological pelvic cancer: a safe and effective palliation.
Regional Cancer Treatment, Suppl. 1, (1997) 45
K. H. Link, L. Staib, H. Bernhart, E.D. Kreuser, P. Suhr, E. Röttinger, H.G. Beger.
Interim report on toxicity compliance of the FOGT 1 and FOGT 2 trials for adjuvant postoperative therapy in colon- and rectal cancer.
European Journal of Cancer, 33, Suppl 8, (1997) 342
K. H. Link, L. Staib, H. Bernhart, E.D. Kreuser, P. Suhr, E. Röttinger, H. G. Beger for the Forschungsgruppe Onkologie Gastrointestinaler Tumoren (FOGT).
Toxicity and compliance of the FOGT-1 and FOGT-2 trials for adjuvant postoperative therapy in colon- and rectal cancer. An Interim Report.
Proceedings 8th International Congress on Anti-Cancer Treatment, Paris (1998) 98
K. H. Link, A. Formentini, G. Leder, H.G. Beger.
Multimodal treatment concepts to improve survival in nonresectable and resectable pancreatic cancer.
Proceedings 8th International Congress on Anti-Cancer Treatment, Paris (1998) 123
K. H. Link, J. Pillasch, A. Formentini, E. Sunelaitis, G. Leder, F. Safi, E. Papachristou, H. Allmendinger, R. Dahlbender, H.G. Beger.
Development of hepatic artery infusion (HAI) protocols in nonresectable isolated colorectal liver metastases (CRLM).
Proceedings 8th International Congress on Anti-Cancer Treatment, Paris (1998) 105
K. H. Link, G. Leder, J. Staib, J. Pillasch, F. Gansauge, M. Kornmann, A. Formentini, U. Butzer, H.G. Beger.
Regional chemotherapy of nonresectable colorectal liver metastases and advanced pancreatic cancer – from basic science to phase II and III studies.
Annals of Cancer Research and Therapy 18 (1998) 34-37.
K. H. Link, L. Staib, E. Röttinger, H.G. Beger.
Toxizität und Akzeptanz der adjuvanten Therapie von Kolon- und Rektumkarzinomen im Rahmen der interdisziplinären FOGT 1 und 2 Studien.
In Ch. Herfarth und W. Hartel (Eds.) Kurzreferate 115. Kongress der Deutschen Gesellschaft für Chirurgie, Barth, Heidelberg (1998) 259
K. H. Link, A. Formentini, J. Pillasch, H.G. Beger
Die regionale Chemotherapie primär nichtresektabler kolorektaler Lebermetastasen kann eine sekundäre Resektabilität induzieren.
In Ch. Herfarth und W. Hartel (Eds.) Kurzreferate 115. Kongress der Deutschen Gesellschaft für Chirurgie, Barth, Heidelberg (1998) 185
K. H. Link, A. Formentini, G. Leder, G. Fortnagel, F. Gansauge, H.G. Beger.
Achievements and developments of regional cancer chemotherapy in non-resectable and resected pancreatic cancer.
European Journal of Surgical Oncology, 24 (1998) 210
K. H. Link, M. Kornmann, G. Leder, K. Danenberg, P. V. Danenberg, H. G. Beger.
Thymidylate synthase (TS) is a prognostic determinant in regional chemotherapy of colorectal liver metastases.
European Journal of Surgical Oncology, 24 (1998) 218
K. H. Link, J. Pillasch, A. Formentini, G. Leder, E. Sunelaitis, H. Allmendinger, E. Papachristou, H.G. Beger.
Intraarterial infusion of malignant liver tumors via ports.
Journal of Cancer Research and Clinical Oncology Suppl. Vol. 124 (1998) R15
K. H. Link, J. Pillasch, G. Leder, A. Formentini, L. Staib, H.G. Beger.
Choice of therapy for liver metastases from colorectal cancer. Regional chemotherapy with the possibility of downstaging and secondary resection.
The Journal of the Japan Society of Coloproctology, 51 9 (1998) P1-1
K. H. Link.
Adjuvant treatment of colon- and rectal cancers. Toxicity analysis of FOGT1- and FOGT 2 trials.
Annals of Hematology Vol 77 (Suppl II) (1998) 106
K. H. Link.
Quality control in colon- and rectal cancer surgery
BMC Proceedings 2010, 4/Suppl 2), O23
K-H. Link for the FOGT.
Surgical oncology and translational research: Ideas, laboratory task, clinical results and merits.
Book of abstracts, 18. Charles Heidelberger Symposium on Cancer Research
“Translational Research from bench to Bedside”, Ulm, 2012
Published abstracts coautor
K. R. Aigner, K.H. Link, H. Walther, K. Schwemmle.
Combined treatment of liver tumors: Isolated perfusion, resection, hepatic artery infusion.
Cancer Research Clinical Oncology 107 (1984) 75
K. R. Aigner, K.H. Link, H. Walther, K. Schwemmle.
Combined treatment of liver tumors: Isolated perfusion, resection, hepatic artery infusion.
Verh.Dtsch. Krebs. Ges. 5, Gustav Fischer, Stuttgart (1984) 489
H. Walther, K.R. Aigner, K.H. Link, K. Schwemmle.
Intraarterial infusion chemotherapy with regional venous drug hemofiltration combined
with surgery in treatment of two cases with malignant tumors.
Cancer Research Clinical Oncology 107 (1984) 64
E. D. Kreuser, K.H. Link, F. Porzsolt, G. Steinmann, P.V. Danenberg.
Heterogenous sensitivity of human colon cancer cell lines to 5-Fluorouracil, Folinic Acid,
and Dipyridamole.
Proceedings of the American Association of Cancer Research (AACR) 30 (1989) 571
E. Thiel, E.D. Kreuser, C. Garbe, K.H. Link, G Steinmann, P.V. Danenberg.
A feasable fluorometric assay for determining interaction of cytokines and drugs in human cancer cell lines.
Cancer Research and Clinical Oncology 116 (1990) 454
L. Staib, R. Kunz, G. Hepp, K.H. Link.
Cyclic intraperitoneal chemotherapy with mitoxantrone (NOV).
Cancer Research and Clinical Oncology 116 (1990) 692
J. M. Friedrich, K.H. Link, K.A. Schumacher.
Port connected endoprosthesis for internal drainage.
Radiology 177 (1990) 251
R. Kunz, L. Staib, J. Sixt, K.H. Link.
Individual chemosensitivity testing at the high concentration range of regional chemotherapy.
Cancer Research and Clinical Oncology, 116 (1990) 601
J.M. Friedrich, K.H. Link, K.A. Schumacher, T. Heuchemer, W. Weidenmaier.
Flushable biliary stent: Long-term results.
Radiology 181 (1991) 215
L. Staib, K.H. Link, M.S. Mitchell.
Immunomodulation of pancreatic cancer in vitro. Effect of monoclonal antibodies, GM-CSF and lymphokine-activated killer cells.
Digestion 52 (1992) 124
F. Gansauge, K. H. Link, M. Büchler, H.G. Beger.
Split-Time resection of ‘unresectable’ colorectal liver metastases supported by chemosensitivity directed hepatic artery infusion.
Regional Cancer Treatment Suppl 1 (1993) 25
S. Gansauge, K. H. Link, M. Hummel, D. Kindler, H.G. Beger .
Establishment and In-Vitro Toxicity Studies of Two New Pancreatic Carcinoma Cell-Lines PMH2/89 and PMH3/89.
J Cancer Res Clin Oncol 20 (1994) 311
F. Gansauge, K. H. Link, W. Schlosser, N. Rilinger, M. Büchler, H.G. Beger.
Effectivity and Toxicity of Regional Chemotherapy in Pancreatic Carcinoma.
Eur J Surg Oncol 20 (1994) 312
F. Gansauge, K. H. Link, J. Pillasch, M. Büchler, H.G. Beger.
Regional Chemotherapy in Advanced Pancreatic Carcinoma.
J Cancer Res Clin Oncol 20 (1994) 74
S. Gansauge, F. Gansauge, K. H. Link, M.H. Schoenberg, B. Poch, H.G. Beger.
Prevention of liver metastases in pancreatic carcinoma by autoantibodies directed against p53.
Int. J. Pancreatol. 16 (1994) 313
S. Gansauge, F. Gansauge, K. H. Link, M. H. Schoenberg, B. Poch, H.G. Beger.
p53-autoantibodies in diseases of the pancreatico-biliary system.
Pancreas 9 (1994) 788
J. Pillasch, K. H. Link, N. Rilinger, L. Staib, H.G. Beger.
Regional Chemotherapy of Primary Hepatic Cancer – Effectivity and Toxicity.
Eur J Surg Oncol 20 (1994) 321
F. Porzsolt, A. Wirth, R. Mayer-Steinacker, W. Voigt, B. Heymer, K. H. Link, M. Schulte, E. Röttinger.
Quality Assurance in Palliative Treatment: Goals Should be Defined, Specified, and Monitored.
ASCO Proceedings 13 (1994) 188
L. Staib, U. Butzer, K. H. Link, H. G. Beger.
Immune Reactivity in Colorectal Cancer Patients.
Eur J Surg Oncol 20 (1994) 267-68
L. Staib, U. Butzer, K. H. Link, H. G. Beger.
Immune Reactivity is Reduced in Patients with Advanced Colorectal Cancer.
Proceedings of the AACR 35 (1994) 249
F. Safi, G. Hepp, K. H. Link, H. G. Beger.
Simultaneous adjuvant regional and systemic chemotherapy after resection of liver metastases of colorectal cancer.
Proceedings of ASCO (Abstract-Book) 14 (1995) 217
F. Gansauge, K. H. Link, N. Rilinger, T. Rehwagen, H. G. Beger.
Regional Chemotherapy in unresectable Pancreatic Cancer.
Proceedings of the Fifth International Congress on Anti-Cancer Chemotherapy. Paris (1995) 150
M. Weindel, J. Pillasch, K. H. Link, N. Rilinger, Ch. Schaller, H. G. Beger.
Regional i.a. chemotherapy of colorectal liver metastases: Effectivity and toxicity of a new drug combination.
Proceedings of the Fifth International Congress on Anti-Cancer Chemotherapy. Paris (1995) 242
A. Formentini, K. H. Link, G. Fortnagel, J. Pillasch, H. G. Beger.
Hepatic artery infusion for chemotherapy of primary and metastatic liver tumors via a port catheter system: a safe and feasible procedure.
Regional Cancer Treatment, Suppl. I, (1997) 12
A. Formentini, K. H. Link, J. Pillasch, H. G. Beger.
Neoadjuvant regional chemotherapy for non resectable pancreatic and hepatic tumors.
Regional Cancer Treatment, Suppl. I, (1997) 60
L. Staib, H. Braunmüller, K. H. Link, H. G. Beger.
Immune reactivity of regional lymph nodes in human pancreatic cancer is decreased compared to blood cells.
Proceedings of the American Association of Cancer Research (AACR) 38 (1997), 121
A. Formentini, K. H. Link, J. Pillasch, H. G. Beger
A seven years experience with implantable devices for regional hepatic arterial chemotherapy: usability time, incidence and management of complications.
European Journal of Cancer, 33, Suppl 8 (1997) 164
J .Görich, N. Rilinger, R. Sokiranksi, S. Krämer, A. Aschoff, K.H. Link, H.J. Brambs.
Intraarterial chemotherapy in recurrent breast cancer.
Journal of Cancer Research and Clinical Oncology Suppl. Vol. 124 (1998), R15
N. Warszawski, K.H. Link, A. Warszawski, B.M. Schneider, E.M. Röttinger.
Treatment factors influencing survival in pancreatic carcinoma.
Journal of Radiation Oncology, Biology, Physics 174 Suppl 1 (1998) 103
F. Gansauge, K. H. Link, C. Rehwagen, H. G. Beger.
Regionale Chemotherapie bei nicht-resezierbarem und palliativ reseziertem Pankreaskarzinom.
Lang. Arch. Chir. Suppl. II (1995) 598
L. Staib, K. H. Link, H. G Beger.
Morbidität und Langzeitüberleben nach Resektion uni- und multizentrischer kolorektaler Karzinome
Dt. Gesellschaft Chirurgie (Kongressband 2001), 835, 2001
L. Staib, K. H. Link, H. D. Harzer, A. Käsbohrer, V. Liebig, H.G Beger.
Adjuvante Therapie des Kolonkarzinoms mit 5-FU/Folinsäure/Levamisol: Überlegenheit in der Kosten-Nutzen Analyse der Mulicenterstudie FOGT-1
Dt. Gesellschaft Chirurgie (Kongressband 2001), 84, 2001
L. Staib, K. H. Link, H. G Beger.
Morbidität und Langzeitüberleben nach Resektion uni- und multizentrischer kolorektaler Karzinome
Dt. Gesellschaft Chirurgie (Kongressband 2001), 835, 2001
M. Kornmann, W. Schwabe, J. Staeter, P. Haeusler, S. Polat, K. Danenberg, P. Danenberg, H. G Beger, D. Behnke, K. H. Link.
Thymidylate synthase quantitation predicts for disease-free survival in colorectal cancer patients receiving adjuvant 5-fluorouracil
American Association for Cancer Research, Annual Meeting, New Orleans, 24.-28.04.01, Proc Am Assoc Cancer Res 42, 662, 2001
M. Kornmann, K. H. Link, S. Sander, M. Kron, J. Straeter, W. Schwabe, P. Haeusler, D. Behnke, H. G. Beger.
Thymidylate synthase and dihydropyrimidine dehydrogenase expression in stage II and III colorectal cancer patients receiving adjuvant 5-fluorouracil
Eur. J. Cancer 37, S300, 2001
M. Kornmann, K. H. Link, W. Schwabe, P. Haeusler, J. Straeter, S. Polat, P. Danenberg, D. Behnke, H.G. Beger.
MRNA quantitation of thymidylate synthase and dihydopyrimidine dehydrogenase can predict disease-free survival in stage II b and III colon and stage II and III rectal cancer
Gastroenterology S870, 2001
M.Kornmann, L.Staib, S.Sander, D.Henne-Bruns, and K.H. Link.
Prognostic factors influencing the outcome of patients with colorectal cancer receiving adjuvant 5-FU based chemotherapy.
AACR Meeting Abstracts Vol.49, A 4459, 2008
Sabine Grösch, Ruth Wanger, Sina Fuchs, Nerea Ferreiros, Gerd Geisslinger, Anna Höh, Anette Fisseler-Eckhoff, Karl-Heinrich Link.
The role of ceramides in colon cancer.
Book of abstracts, 18. Charles Heidelberger Symposium on Cancer Research “Translational Research from bench to Bedside”, Ulm, 2012
L. Staib, T. Renz, F. Schuilcher, B. Hübner, K. Schüle, M. Geissler, H. Gnann, M. Kornmann, K.H. Link.
Neoadjuvant rediochemotherapy in advanced rectal cancer – a single institution experience.
Book of abstracts, 18. Charles Heidelberger Symposium on Cancer Research “Translational Research from bench to Bedside”, Ulm, 2012
L. Staib, M. Kornmann, D. Henne-Bruns, K.H. Link.
How accurate is preoperative local staging in resectable rectal cancer?
Book of abstracts, 18. Charles Heidelberger Symposium on Cancer Research “Translational Research from bench to Bedside”, Ulm, 2012
Casuistics/Case reports
K. H. Link und J. Kracht.
Malakoplakie der Urethra – Eine außergewöhnliche Lokalisation.
Pathologe 2, 106-110, 1981
W. Weidner, R. Pust, J. Kracht, K. H. Link.
Sekundäre Harnleiterobstruktion bei metastasierendem Magenkarzinom – Eine Kasuistik.
Verhandlungsbericht der Deutschen Gesellschaft für Urologie, 34. Tagung, 420-423, 1982,
P. Hild, K. H. Link.
Maligne entartetes Steißbeinteratom beim Erwachsenen.
Chirurg 53, 117-119, 1982